HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07).

Abstract
The novel aryl phosphate derivative of bromo-methoxy zidovudine (ZDV/AZT) (compound WHI-07, CAS 213982-96-8) was found to be a potent antileukemic agent against human leukemia, lymphoma, and multiple myeloma cell lines in MTT and clonogenic assays with low micromolar IC50 values. In addition, WHI-07 was antimitotic, leading to cell fusion and developmental arrest in the Zebrafish model of rapid cell proliferation. WHI-07 was cytotoxic to drug-sensitive (NALM-6, MOLT-3, HL-60, P388) and multi-drug resistant (MDR) leukemia cell lines (HL-60/VCR, HL-60/ADR, P388/ ADR). Treatment of leukemia cells with WHI-07 showed rapid and dramatic depletion of all cellular nucleoside diphosphate and triphosphate (NDP/NTP) pools, which would contribute to the overall reduction of nucleic acid synthesis and cell death. WHI-07 was rapidly metabolized to alaninyl ZDV monophosphate (Ala-ZDV-MP), the levels of which inversely correlated with cytotoxic IC50 values of WHI-07. Glutathione was found to mediate the in vitro and in vivo detoxification pathway of WHI-07 to 3'-azidothymidine-5'-p-bromophenylmethoxyalaninyl phosphate and Ala-ZDV-MP, respectively. The proposed intracellular metabolic pathway for WHI-07 involves a thiol-mediated dehalogenation step followed by the paraoxon-sensitive carboxylesterase-mediated reaction leading to the formation of Ala-ZDV-MP as the major intracellular metabolite.
AuthorsFatih M Uckun, Hung-Liang Tai, Osmond J D'Cruz
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 55 Issue 1 Pg. 50-65 ( 2005) ISSN: 0004-4172 [Print] Germany
PMID15727164 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 5-bromo-6-methoxy-5, 6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate
  • Antimetabolites, Antineoplastic
  • Cholinesterase Inhibitors
  • Dideoxynucleotides
  • Nucleosides
  • Tetrazolium Salts
  • Thiazoles
  • Rhodamine 123
  • Thymidine Monophosphate
  • Zidovudine
  • Carboxylic Ester Hydrolases
  • thiazolyl blue
  • Glutathione
  • Paraoxon
Topics
  • Animals
  • Antimetabolites, Antineoplastic (metabolism, pharmacology)
  • Biotransformation
  • Carboxylic Ester Hydrolases (antagonists & inhibitors, metabolism)
  • Cell Division (drug effects)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Cholinesterase Inhibitors (pharmacology)
  • Dideoxynucleotides
  • Drug Resistance, Multiple
  • Embryo, Nonmammalian
  • Glutathione (metabolism)
  • Humans
  • Leukemia (drug therapy)
  • Nucleosides (metabolism)
  • Paraoxon (pharmacology)
  • Rhodamine 123 (metabolism)
  • Subcellular Fractions
  • Tetrazolium Salts
  • Thiazoles
  • Thymidine Monophosphate (analogs & derivatives, metabolism, pharmacology)
  • Tumor Stem Cell Assay
  • Zebrafish
  • Zidovudine (analogs & derivatives, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: